These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26822323)

  • 21. Spectrum of somatic mutations detected by targeted next-generation sequencing and their prognostic significance in adult patients with acute lymphoblastic leukemia.
    Feng J; Li Y; Jia Y; Fang Q; Gong X; Dong X; Ru K; Li Q; Zhao X; Liu K; Wang M; Tian Z; Jia Y; Wang Y; Lin D; Wei H; Tang K; Mi Y; Wang J
    J Hematol Oncol; 2017 Feb; 10(1):61. PubMed ID: 28245838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accurate Sample Assignment in a Multiplexed, Ultrasensitive, High-Throughput Sequencing Assay for Minimal Residual Disease.
    Bartram J; Mountjoy E; Brooks T; Hancock J; Williamson H; Wright G; Moppett J; Goulden N; Hubank M
    J Mol Diagn; 2016 Jul; 18(4):494-506. PubMed ID: 27183494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of Immunoglobulin Heavy Chain Gene Clonality by Next-Generation Sequencing for Minimal Residual Disease Monitoring in B-Lymphoblastic Leukemia.
    Shin S; Hwang IS; Kim J; Lee KA; Lee ST; Choi JR
    Ann Lab Med; 2017 Jul; 37(4):331-335. PubMed ID: 28445014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunoglobulin gene rearrangement in detection of minimal residual disease in acute lymphoblastic leukaemia.
    Nayyar A; Ahmed S
    J Ayub Med Coll Abbottabad; 2013; 25(1-2):159-61. PubMed ID: 25098084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early Response-Based Therapy Stratification Improves Survival in Adult Early Thymic Precursor Acute Lymphoblastic Leukemia: A Group for Research on Adult Acute Lymphoblastic Leukemia Study.
    Bond J; Graux C; Lhermitte L; Lara D; Cluzeau T; Leguay T; Cieslak A; Trinquand A; Pastoret C; Belhocine M; Spicuglia S; Lheritier V; Leprêtre S; Thomas X; Huguet F; Ifrah N; Dombret H; Macintyre E; Boissel N; Asnafi V
    J Clin Oncol; 2017 Aug; 35(23):2683-2691. PubMed ID: 28605290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiplex technologies for the assessment of minimal residual disease and low-level mutation detection in leukaemia: mass spectrometry versus next-generation sequencing.
    Shanmuganathan N; Branford S
    Br J Haematol; 2022 Jan; 196(1):19-30. PubMed ID: 34124782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An early thymic precursor phenotype predicts outcome exclusively in HOXA-overexpressing adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study.
    Bond J; Marchand T; Touzart A; Cieslak A; Trinquand A; Sutton L; Radford-Weiss I; Lhermitte L; Spicuglia S; Dombret H; Macintyre E; Ifrah N; Hamel JF; Asnafi V
    Haematologica; 2016 Jun; 101(6):732-40. PubMed ID: 26944475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PTK7: a new biomarker for immunophenotypic characterization of maturing T cells and T cell acute lymphoblastic leukemia.
    Jiang G; Zhang M; Yue B; Yang M; Carter C; Al-Quran SZ; Li B; Li Y
    Leuk Res; 2012 Nov; 36(11):1347-53. PubMed ID: 22898210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Linking genomic lesions with minimal residual disease improves prognostic stratification in children with T-cell acute lymphoblastic leukaemia.
    La Starza R; Lettieri A; Pierini V; Nofrini V; Gorello P; Songia S; Crescenzi B; Te Kronnie G; Giordan M; Leszl A; Valsecchi MG; Aversa F; Basso G; Biondi A; Conter V; Cazzaniga G; Mecucci C
    Leuk Res; 2013 Aug; 37(8):928-35. PubMed ID: 23735857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Will Daratumumab be the next game changer in early thymic precursor-acute lymphoblastic leukaemia?
    Mirgh S; Ahmed R; Agrawal N; Khushoo V; Garg A; Francis S; Tejwani N; Singh N; Bhurani D
    Br J Haematol; 2019 Oct; 187(2):e33-e35. PubMed ID: 31452197
    [No Abstract]   [Full Text] [Related]  

  • 31. Detection of T-cell receptor delta gene rearrangement in T-cell malignancies by clonal specific polymerase chain reaction and its application to detect minimal residual disease.
    Chan DW; Liang R; Kwong YL; Chan V
    Am J Hematol; 1996 Jul; 52(3):171-7. PubMed ID: 8756082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Minimal residual disease levels in bone marrow and peripheral blood are comparable in children with T cell acute lymphoblastic leukemia (ALL), but not in precursor-B-ALL.
    van der Velden VH; Jacobs DC; Wijkhuijs AJ; Comans-Bitter WM; Willemse MJ; Hählen K; Kamps WA; van Wering ER; van Dongen JJ
    Leukemia; 2002 Aug; 16(8):1432-6. PubMed ID: 12145681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-3 receptor α chain (CD123) is preferentially expressed in immature T-ALL and may not associate with outcomes of chemotherapy.
    Du W; Li J; Liu W; He Y; Yao J; Liu Y; Lin J; Zheng J
    Tumour Biol; 2016 Mar; 37(3):3817-21. PubMed ID: 26474588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Achieving Molecular Remission before Allogeneic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Impact on Relapse and Long-Term Outcome.
    Lussana F; Intermesoli T; Gianni F; Boschini C; Masciulli A; Spinelli O; Oldani E; Tosi M; Grassi A; Parolini M; Audisio E; Cattaneo C; Raimondi R; Angelucci E; Cavattoni IM; Scattolin AM; Cortelezzi A; Mannelli F; Ciceri F; Mattei D; Borlenghi E; Terruzzi E; Romani C; Bassan R; Rambaldi A
    Biol Blood Marrow Transplant; 2016 Nov; 22(11):1983-1987. PubMed ID: 27492792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigation of minimal residual disease in childhood and adult acute lymphoblastic leukaemia by molecular analysis.
    Foroni L; Harrison CJ; Hoffbrand AV; Potter MN
    Br J Haematol; 1999 Apr; 105(1):7-24. PubMed ID: 10366253
    [No Abstract]   [Full Text] [Related]  

  • 36. [Characteristics of T cell receptor beta gene rearrangements and its role in minimal residual disease detection in childhood T-cell acute lymphoblastic leukemia].
    Liu JY; Li ZG; Gao C; Cui L; Wu MY
    Zhonghua Er Ke Za Zhi; 2008 Jul; 46(7):487-92. PubMed ID: 19099802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MRD-risk stratification mitigates TLX3 prognostic impact in paediatric T-cell acute lymphoblastic leukaemia: A national cohort analysis.
    Trinquand A; Betts DR; Rooney S; Storey L; McCarthy P; Barrett N; Broderick V; Evans P; Bond J; O'Marcaigh A; Malone A; Smith OP
    Br J Haematol; 2024 Aug; 205(2):729-732. PubMed ID: 38937136
    [No Abstract]   [Full Text] [Related]  

  • 38. Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood.
    Matsumura T; Kami M; Saito T; Sakamaki H; Hirai H
    Lancet; 1999 Feb; 353(9154):752-3. PubMed ID: 10073540
    [No Abstract]   [Full Text] [Related]  

  • 39. Rapid Capture Next-Generation Sequencing in Clinical Diagnostics of Kinase Pathway Aberrations in B-Cell Precursor ALL.
    Stadt UZ; Escherich G; Indenbirken D; Alawi M; Adao M; Horstmann MA
    Pediatr Blood Cancer; 2016 Jul; 63(7):1283-6. PubMed ID: 27007619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Minimal Residual Disease Monitoring with Next-Generation Sequencing Methodologies in Hematological Malignancies.
    Sánchez R; Ayala R; Martínez-López J
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31185671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.